Boston Scientific Corporation logo

Boston Scientific Corporation (BSX)

Market Closed
10 Aug, 20:00
NYSE NYSE
$
50. 46
+1.15
+2.3322%
$
70.96B Market Cap
74.55 P/E Ratio
- Div Yield
18.99M Volume
2.01 Eps
$ 49.31
Previous Close
Add Transaction
Day Range
49.54 50.82
Year Range
42.2 109.5
Want to track BSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?

Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 3 months ago
Boston Scientific (BSX) Stock Slides as Market Rises: Facts to Know Before You Trade

Boston Scientific (BSX) Stock Slides as Market Rises: Facts to Know Before You Trade

Boston Scientific (BSX) closed at $61.28 in the latest trading session, marking a -2.05% move from the prior day.

Zacks | 4 months ago
Boston Scientific (BSX) Stock Sinks As Market Gains: Here's Why

Boston Scientific (BSX) Stock Sinks As Market Gains: Here's Why

In the most recent trading session, Boston Scientific (BSX) closed at $61.86, indicating a -1.17% shift from the previous trading day.

Zacks | 4 months ago
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term

Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 months ago
Boston Scientific: From Hypergrowth To Durable Compounding

Boston Scientific: From Hypergrowth To Durable Compounding

Boston Scientific has declined over 35% in six months, yet maintains double-digit growth and 28% operating margins, creating a compelling buy opportunity. BSX trades at mid-tier valuations, despite a 5-year revenue CAGR of 15.1% and EBITDA CAGR of 19%, outpacing Medtronic and Edwards Lifesciences. Growth drivers include electrophysiology, the WATCHMAN CHAMPION trial, and M&A, with the potential to expand the addressable market and sustain 11% EPS growth.

Seekingalpha | 4 months ago
Here's Why Boston Scientific (BSX) Fell More Than Broader Market

Here's Why Boston Scientific (BSX) Fell More Than Broader Market

In the closing of the recent trading day, Boston Scientific (BSX) stood at $62.93, denoting a -9.02% move from the preceding trading day.

Zacks | 4 months ago
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks | 4 months ago
Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo Transcript

Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo Transcript

Boston Scientific Corporation (BSX) Presents at American College of Cardiology 75th Annual Scientific Session and Expo Transcript

Seekingalpha | 4 months ago
Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know

Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know

Boston Scientific (BSX) concluded the recent trading session at $68.15, signifying a -2% move from its prior day's close.

Zacks | 4 months ago
Why Boston Scientific (BSX) Outpaced the Stock Market Today

Why Boston Scientific (BSX) Outpaced the Stock Market Today

Boston Scientific (BSX) closed the most recent trading day at $71.2, moving +2.02% from the previous trading session.

Zacks | 4 months ago
Banco Bilbao Vizcaya Argentaria S.A. Raises Stake in Boston Scientific Corporation $BSX

Banco Bilbao Vizcaya Argentaria S.A. Raises Stake in Boston Scientific Corporation $BSX

Banco Bilbao Vizcaya Argentaria S.A. raised its position in Boston Scientific Corporation (NYSE: BSX) by 194.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 104,785 shares of the medical equipment provider's stock after purchasing an additional 69,174 shares

Defenseworld | 4 months ago
Alliancebernstein L.P. Decreases Stock Holdings in Boston Scientific Corporation $BSX

Alliancebernstein L.P. Decreases Stock Holdings in Boston Scientific Corporation $BSX

Alliancebernstein L.P. reduced its position in Boston Scientific Corporation (NYSE: BSX) by 9.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,986,478 shares of the medical equipment provider's stock after selling 302,058 shares during the period. Alliancebernstein L.P. owned 0.20% of Boston Scientific

Defenseworld | 4 months ago
Loading...
Load More